Callan Capital LLC Sells 542 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Callan Capital LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,770 shares of the healthcare conglomerate’s stock after selling 542 shares during the period. Callan Capital LLC’s holdings in UnitedHealth Group were worth $895,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth about $37,000. DecisionPoint Financial LLC lifted its holdings in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $57,000. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $465.58 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock’s fifty day moving average price is $519.27 and its 200-day moving average price is $560.54. The company has a market cap of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on UNH shares. Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays dropped their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.